<DOC>
	<DOCNO>NCT02041364</DOCNO>
	<brief_summary>Fatigue common cancer patient receive adjuvant chemotherapy . To understand mechanism fatigue search potential biomarkers , conduct prospective study breast cancer patient receive adjuvant chemotherapy .</brief_summary>
	<brief_title>Biomarkers Fatigue Related Adjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description>Patients breast cancer undergo adjuvant systemic chemotherapy base use anthracyclines screen start chemotherapy . Patients whose score brief fatigue inventory ( BFI ) increase receive first cycle chemotherapy consider manifested fatigue . The patient whose fatigue wo n't worse follow first cycle chemotherapy use control . We collect blood sample group 21 day start chemotherapy . We analyze follow biomarkers : IL2 , IL10 , TNF TGFB-1 measure amplification reaction ; FSH , LH , estradiol , DHEA , DHEAS cortisol hormone measure chemiluminescent enzyme immunometric assay</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Non metastatic breast cancer ; Patients undergo adjuvant chemotherapy hypothyroidism ; Depression ; anemia ; heart disease decompensated hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Fatigue</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Breast Cancer</keyword>
</DOC>